
Objectives
Align branding, key clinical messages and materials across UTEL’s corporate brand and its growing portfolio of products - beginning with Romdulin, a treatment in Pulmonary Arterial Hypertension, and extending into new treatment areas / delivery mechanisms. Support UTEL’s sales and marketing affiliates across Europe aligning marketing collateral.
Strategy and tactics
Assess existing materials and create:
Consensus of data and key messages – a new positioning
Rationalize brand hierarchy across portfolio
Develop new creative platform
Create brand expression guide
Develop new core materials
Results
A clear visual identity for UTEL’s corporate brand and its reorganised portfolio of product brands.